Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide has shown significant potential in diabetes treatment and weight management applications.
The compound works through multiple mechanisms of action. As a GIP receptor agonist, it enhances insulin secretion in a glucose-dependent manner. Simultaneously, its GLP-1 receptor agonist activity promotes satiety, slows gastric emptying, and reduces food intake. These combined effects contribute to both glycemic control and weight reduction.
Our tirzepatide prices are highly competitive for research institutions and pharmaceutical developers. The product is supplied in lyophilized powder form with comprehensive analytical documentation including HPLC purity reports and mass spectrometry verification.
For proper storage, maintain the peptide in a cool, dry environment protected from light. The lyophilized powder remains stable at -20°C for extended periods. Avoid repeated freeze-thaw cycles of reconstituted solutions.
Key advantages of our tirzepatide supply include batch-to-batch consistency, rigorous quality control, and flexible packaging options. We offer various vial sizes to accommodate different research needs while maintaining competitive tirzepatide prices for bulk purchases.
Please note this product is intended for research purposes only. All orders require verification of research credentials and institutional affiliation. Our technical support team is available to assist with protocol development and application questions.
